| Pharmaceutical Information |
| Drug Name |
Rimexolone |
| Drug ID |
BADD_D01946 |
| Description |
Rimexolone is a 1% eye drop solution is a glucocorticoid steroid. It is used to treat inflammation in the eye. It is marketed as Vexol. |
| Indications and Usage |
For the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis. |
| Marketing Status |
Discontinued |
| ATC Code |
H02AB12; S01BA13 |
| DrugBank ID |
DB00896
|
| KEGG ID |
D05729
|
| MeSH ID |
C013769
|
| PubChem ID |
5311412
|
| TTD Drug ID |
D0D2TN
|
| NDC Product Code |
60870-0423 |
| Synonyms |
rimexolone | 11 beta-hydroxy-16 alpha,17 alpha,21-trimethylpregna-1,4-diene-3,20-dione | Rimexel | Vexol | Org 6216 | Org-6216 |
|
| Chemical Information |
| Molecular Formula |
C24H34O3 |
| CAS Registry Number |
49697-38-3 |
| SMILES |
CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
